Arkolith/Insider Trading/XBIT/Form 4

Simard John

Chief Executive Officer, Director, 10% OwnerXBiotech Inc. (XBIT) · full profile →Form 4 · filed Jan 5, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
0 non-derivative · 1 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 3, 2024Buy(P)2.5M$10000000.00$24.7T3.8M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-002316) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML